Members Trust
GILD icon

Members Trust’s Gilead Sciences GILD Stock Holding History

Members Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,179
Closed -$216K – 80
2017
Q1 		$216K Buy
+3,179
New +$224K 0.01% 77
2016
Q3 		$221K Buy
2,791
+151
+6% +$12.3K 0.01% 83
2016
Q2 		$220K Buy
+2,640
New +$234K 0.01% 81

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Members Trust's GILD Position: Q2 2017 in Review

Members Trust sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 3,179 shares — an estimated $216K sold.

Members Trust first reported a position in GILD in Q2 2016 and held it in 3 quarters. The position peaked at $221K in Q3 2016. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Members Trust reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Members Trust sold 3,179 Gilead Sciences shares in Q2 2017, an estimated $216K.
  • Members Trust first reported a position in Gilead Sciences in Q2 2016 and held it in 3 quarters.
  • Members Trust's Gilead Sciences position peaked at $221K in Q3 2016.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Members Trust's 13F filing for Q2 2017, filed 7 Aug 2017.